The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

In this video interview, David Morton, PhD, director of biostatistics at Certara, discusses how growing FDA support is accelerating the adoption of Bayesian approaches, enabling more flexible, ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...

Bayesian methods have emerged as a robust framework for assessing system reliability in environments marked by uncertainty and limited data availability. By incorporating prior knowledge and updating ...

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...

We review Bayesian and Bayesian decision theoretic approaches to subgroup analysis and applications to subgroup-based adaptive clinical trial designs. Subgroup analysis refers to inference about ...